Publications - Timothy O. Wilson, M.D.

Back to research profile

1. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011 Oct; 123(1):58-64. Epub 2011 Jul 13.
   View PubMed
2. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26.
   View PubMed
3. Rollene N, Nunn M, Wilson T, Coddington C. Recurrent ovarian torsion in a premenarchal adolescent girl: contemporary surgical management. Obstet Gynecol. 2009 Aug; 114(2 Pt 2):422-4.
   View PubMed
4. Aletti GD, Powless C, Bakkum-Gamez J, Wilson TO, Podratz KC, Cliby WA. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy. Gynecol Oncol. 2009 Jul; 114(1):32-6. Epub 2009 Apr 09.
   View PubMed
5. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilson TO, Podratz KC, Cliby WA. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J Am Coll Surg. 2009 Apr; 208(4):614-20.
   View PubMed
6. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr; 109(1):11-8. Epub 2008 Mar 04.
   View PubMed
7. Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey. J Cancer Educ. 2007 Winter; 22(4):208-18.
   View PubMed
8. Cliby WA, Aletti GD, Wilson TO, Podratz KC. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006 Dec; 103(3):797-801. Epub 2006 Oct 18.
   View PubMed
9. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006 Jan; 107(1):77-85.
   View PubMed
10. Feitoza SS, Gebhart JB, Gostout BS, Wilson TO, Cliby WA. Efficacy of thermal balloon ablation in patients with abnormal uterine bleeding. American Journal of Obstetrics & Gynecology. 2003 Aug; 189(2):453-7.
    View PubMed
11. Carley ME, Klingele CJ, Gebhart JB, Webb MJ, Wilson TO. Laparoscopy versus laparotomy in the management of benign unilateral adnexal masses. J Am Assoc Gynecol Laparosc. 2002 Aug; 9(3):321-6.
    View PubMed
12. Dowdy SC, Boardman CH, Wilson TO, Podratz KC, Hartmann LC, Long HJ. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer. Am J Obstet Gynecol. 2002 Jun; 186(6):1167-73.
    View PubMed
13. Meath AJ, Carley ME, Wilson TO. Atypical glandular cells of undetermined significance. Review of final histologic diagnoses. J Reprod Med. 2002 Apr; 47(4):249-52.
    View PubMed
14. Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int J Radiat Oncol Biol Phys. 1997 Mar 1; 37(4):839-43.
    View PubMed
15. Haddock MG, Petersen IA, Webb MJ, Wilson TO, Podratz KC, Gunderson LL. IORT for locally advanced gynecological malignancies. Front Radiat Ther Oncol. 1997; 31:256-9.
    View PubMed
16. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol. 1996 Aug; 62(2):192-8.
    View PubMed
17. Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol. 1996 Feb; 60(2):288-91.
    View PubMed
18. Torres VE, Bjornsson J, King BF, Kumar R, Zincke H, Edell ES, Wilson TO, Hattery RR, Gomez MR. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc. 1995 Jul; 70(7):641-8.
    View PubMed
19. Moen MD, Webb MJ, Wilson TO, Lee RA. Vaginal hysterectomy in patients with benign uterine enlargement. J Pelvic Surgery. 1995 1; 1:197-203.
20. Clark CL, Wilson TO, Witzig TE. Giant uterine fibromyoma producing secondary polycythemia. Obstet Gynecol. 1994 Oct; 84(4 Pt 2):722-4.
    View PubMed
21. Moen MD, Cliby WA, Wilson TO. Stage III papillary serous cystadenocarcinoma of the ovary in a 15-year-old female. Gynecol Oncol. 1994 May; 53(2):274-6.
    View PubMed
22. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O'Brien PC, van Heerden JA. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994 Feb; 219(2):112-9.
    View PubMed
23. Van Winter JT, Wilson TO. Vulvar cancer with bulky nodal metastasis in a young woman. A case report. J Reprod Med. 1994 Jan; 39(1):46-8.
    View PubMed
24. Podratz KC, Wilson TO, Gaffey TA, Cha SS, Katzmann JA. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. American Journal of Obstetrics & Gynecology. 1993 Apr; 168(4):1206-13; discussion 1213-5.
    View PubMed
25. Garton GR, Gunderson LL, Webb MJ, Wilson TO, Martenson JA Jr, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience. Gynecol Oncol. 1993 Mar; 48(3):328-32.
    View PubMed
26. Heise RH, Van Winter JT, Wilson TO, Ogburn PL Jr. Colonic cancer during pregnancy: case report and review of the literature. Mayo Clin Proc. 1992 Dec; 67(12):1180-4.
    View PubMed
27. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol. 1992 Nov; 47(2):179-85.
    View PubMed
28. Stanhope CR, Wilson TO, Utz WJ, Smith LH, O'Brien PC. Suture entrapment and secondary ureteral obstruction. American Journal of Obstetrics & Gynecology. 1991 Jun; 164(6 Pt 1):1513-7; discussion 1517-9.
    View PubMed
29. Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc. 1990 May; 65(5):643-50.
    View PubMed
30. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD, O'Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. American Journal of Obstetrics & Gynecology. 1990 Feb; 162(2):418-23; discussion 423-6.
    View PubMed
31. Lentz SS, Schray MF, Wilson TO. Chylous ascites after whole-abdomen irradiation for gynecologic malignancy. Int J Rad Oncol Biol Phys. 1990; l9:435.
32. Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol Oncol. 1989 Sep; 34(3):317-22.
    View PubMed